Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02724462 · ClinicalTrials.gov registry record · NA
Trial of An Innovative Smartphone Intervention for Smoking Cessation
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2,503
- Enrollment target
NCT02724462: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT02724462 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 2,503 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02724462, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,503 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.
Primary Outcome
Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are excluded for the complete-case analysis. Exact 2-sided CI was based on the observed proportion of participants.
Interventions
- BEHAVIORAL Smartphone-delivered Intervention (SmartQuit)
- BEHAVIORAL : Smartphone-delivered Intervention (Standard of care app)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,503 participants |
| Start Date | 2017-05-27 |
| Est. Completion | 2019-12-27 |
| Phase | NA |
What the finished NCT02724462 record still lists
NCT02724462 is an interventional study that assigns participants to a tested intervention. Its 2,503 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher).
The record links to 0 conditions, and to 2 interventions - of which Smartphone-delivered Intervention (SmartQuit) is the first listed.
NCT02724462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02724462 about?
NCT02724462 is a clinical study titled "Trial of An Innovative Smartphone Intervention for Smoking Cessation". The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.
What is the current status of trial NCT02724462?
This trial is currently completed. It is a NA study. The enrollment target is 2,503 participants. The study started on 2017-05-27. Estimated completion is 2019-12-27.
What interventions are being tested in trial NCT02724462?
The interventions under investigation include: Smartphone-delivered Intervention (SmartQuit) (BEHAVIORAL), : Smartphone-delivered Intervention (Standard of care app) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02724462?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02724462's enrollment target sits among peer trials
2,503 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI